<?xml version="1.0" encoding="UTF-8"?><REUTERS CGISPLIT="TRAINING-SET" LEWISSPLIT="TRAIN" NEWID="3733" OLDID="8646" TOPICS="YES">
<DATE>11-MAR-1987 11:43:34.51</DATE>
<TOPICS/>
<PLACES><D>usa</D></PLACES>
<PEOPLE/>
<ORGS/>
<EXCHANGES/>
<COMPANIES/>
<UNKNOWN> 
   F
   f0657 reute
d f BC-PRAGMA-BIO-TECH-&lt;PRAG   03-11 0055</UNKNOWN>
<TEXT> 
<TITLE>PRAGMA BIO-TECH &lt;PRAG&gt; IN NITROGLYCERIN TESTING</TITLE>
<DATELINE>    BLOOMFIELD, N.J., March 11 - </DATELINE><BODY>Pragma Bio-Tech Inc, a
clinical testing company, said it has started performing
comparative studies on differnet varieties of nitroglycerin for
use in the treatment of angina pectoris episodes.
    The company would not disclose details of the testing.
 Reuter
 </BODY></TEXT>
</REUTERS>